A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF

Clinical trial NCT07653100 · RECRUITING

Trial details

NCT number: NCT07653100
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2026-06-22
Primary completion: 2027-01-25
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.